The National Agency for Food and Drug Administration and Control (NAFDAC) has commended President Bola Tinubu for signing the new executive order targeted at drug cost reduction and more affordable healthcare.
The Director General of NAFDAC, Prof Mojisola Adeyeye said that the new executive order signed by the President is aimed at transforming the country’s healthcare sector by increasing local production of healthcare products, and promoting local investments.
Adeyeye said in a statement on Saturday that zero tariffs and excise duties for specified pharmaceutical machinery, equipment, goods and accessories are part of the measures included in the Executive Order.
She stated: “Encouraging local manufacturing will create jobs, stimulate economic growth, and reduce dependence on imports, ensuring a reliable supply of essential healthcare products.
“The President’s EO underscores his administration’s commitment to transforming Nigeria’s health sector. It aligns with the broader objectives of the NHSRII and the Presidential Initiative on Healthcare Value Chain (PVAC), approved in October 2023.
“By addressing core challenges and providing a clear path for improvement, this EO sets the stage for a sustainable and high-quality healthcare system for all Nigerians”.
